Interv Akut Kardiol. 2010;9(5):244-250

Percutaneous treatment of bifurcation stenoses

Pavel Červinka
Klinika kardiologie, Krajská zdravotní a. s., Masarykova nemocnice Ústí nad Labem, o. z.
a Univerzita J. E. Purkyně, Ústí nad Labem

Although the introduction of drug-eluting stents (DES) in the clinical practice has substantially contributed to the treatment of patients

with ischaemic heart disease (IHD) and allowed percutaneous treatment of even very complex lesions, the treatment of bifurcation stenoses

still remains a challenge for interventional cardiologists today. Even thirty years after the introduction of percutaneous coronary

intervention (PCI) in the treatment of IHD there is no uniform approach to the percutaneous treatment of lesions located at coronary

bifurcations as indicated by a wide range of more or less technically demanding techniques. The aim of this paper is to provide a current

overview of and practical directions for the treatment of bifurcation stenoses.

Keywords: percutaneous coronary intervention, bifurcation stenoses, drug-eluting stents, stents for bifurcation lesions

Published: November 30, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Červinka P. Percutaneous treatment of bifurcation stenoses. Interv Akut Kardiol. 2010;9(5):244-250.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Steigen TK, et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study. Circulation 2006; 114: 1955-1961. Go to original source... Go to PubMed...
    2. Al Suwadi J, Yeh W, Cohen HA, et al. Immediate and oneyear outcome in patients with coronary bifurcation lesions in the modern ra (NHLBI dynamic registry). Am J Cardiol 2001; 87: 1139-1144. Go to original source... Go to PubMed...
    3. Suzuki N, Angiolillo DJ, Kawaguchi R, et al. Percutaneous coronary intervention of bifurcation coronary disease. Minerva Cardioangiol 2007; 55: 57-71. Go to PubMed...
    4. Cervinka P, Foley D, Sabaté M, et al. Coronary bifurcation stenting using dedicated bifurcation stents. Catheter Cardiovasc Interv. 2000; 49(1): 105-111. Go to original source...
    5. Cervinka P, Stasek J, Pleskot M, et al. Treatment of coronary bifurcation lesions by stent implantation only in parent vessel and angioplasty in sidebranch: immediate and long-term outcome. J Invasive Cardiol 2002; 14(12): 735-740. Go to PubMed...
    6. Cervinka P, Bystroň M, Špaček R, et al. Treatment of bifurcation lesions using dedicated bifurcation stents versus classic bare-metal stzent. Randomized contraolled trial with 12-month angiographic follow-up. J Invasive Cardiol 2008; 20(10): 515-520.
    7. Popma JJ, Leon MB, Topol EJ. Atlas of interventional cardiology. Philadelphia: Saunders, 1994: 77.
    8. Medina A, Suarez de Lezo J, Pan M. A new classification of coronary bifurcation lesions. Rev Esp Cardiol 2006; 59: 183. Go to original source...
    9. Sousa JE, Costa MA, Abizaid AC, et al. Sustained Supression of Neointimal Proliferation bz Sirolimus-Eluting Stents. OneYear Angiographic and Intravascular Ultrasound Follow-up. Circulation 2001; 104: 2007-2011. Go to original source... Go to PubMed...
    10. Morice MC, Serruys PW, and Sousa JE, et al., A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization, N Engl J Med 2002; 346: 1773-1780. Go to original source... Go to PubMed...
    11. Moses JW, Leon MB, Popma JJ, et al. and SIRIUS Investigators, Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery, N Engl J Med 2003; 349: 1315-1323. Go to original source... Go to PubMed...
    12. Stone GW, Ellis SG, Cox DA, et al. and TAXUS-IV Investigators, A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease, N Engl J Med 2004; 350: 221-231. Go to original source... Go to PubMed...
    13. Červinka P, Costa MA, Angiolillo DJ, et al. Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: An intravascular ultrasound study. Catheter Cardiovasc Interv. 2006; 67: 846-851. Go to original source... Go to PubMed...
    14. Stettler CH, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. The Lancet, 2007; 370(9591): 937-948. Go to original source... Go to PubMed...
    15. Cervinka P, Jakabcin J, Jager J, et al. Long-term health outcome and mortality evaluation after invasive treatment using drug-eluting stents: HOME DES registry. Coron Artery Dis 2007; 18(7): 577-581. Go to original source... Go to PubMed...
    16. Pfisterer M, Brunner-La Rocca HP, Buder PT, et al. Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents. An Observational Study of Drug-Elutimg Versus Bare-Metal Stents. J Am Coll Cardiol 2006; 48: 2584-2591. Go to original source... Go to PubMed...
    17. Iakovou I, Schmidt T, Bonizzoni F, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130. Go to original source... Go to PubMed...
    18. Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004; 109: 1244-1249. Go to original source... Go to PubMed...
    19. Hoye A, Iakovou I, Ge L, et al. Long-Term Outcomes After Stenting of Bifurcation Lesions With the, ,Crush" Technigue. Preictors of an Averse Outcome J Am Coll Cardiol 2006; 47: 1949-1958. Go to original source... Go to PubMed...
    20. Koo BK, Kang HJ, Chae IH, et al. Physiologic Assessment of Jailed Side Branch Lesions Using Fractional Flow Reserve J Am Coll Cardiol, 2005; 46: 633-637. Go to original source... Go to PubMed...
    21. Szabo S, Abramowitz B, Vaitkus PT. New technique for aortoostial stent placement. Am J Cardiol 2005; 96: 212H.
    22. Latib A, Colombo A. Manageement of bifurcation lesions. C2I2 2007; 5(2).
    23. Chevalier B, Glatt B, Royer T, Gyuon P. Placement of coronary stents in bifurcation lesions by the, ,Culotte" technique. Am J cardiol 1998; 82: 943-949. Go to original source... Go to PubMed...
    24. Lefevre T, Ormiston J, Gaugliumi G, et al. The Frontier stent registry: safety anf feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions. J Am. Coll. Cardiol. 46: 592-598. Go to PubMed...
    25. Verheye S, Agostini P, Dubois CL, et al. 9-month clinical, angiographic and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9- eluting stent in coronary bifurcation lesions. J Am. Coll. Cardiol. 2009; 53: 1031-1039. Go to original source... Go to PubMed...
    26. Grube E. Sideguard I and II trials. TCT 2009, San Fracisco, USA.
    27. Kaplan AV, Davis HR. Tryton Side-Branch Stent. Eurointervention 2006; 2: 270-272. Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.